Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors. Its structure supports the formation of biologically active compounds targeting inflammatory diseases and certain cancers. The cyano-pyridine moiety enhances binding affinity to enzyme active sites, while the piperidine-carbamate group improves solubility and stability during drug formulation. Commonly employed in research settings for optimizing lead compounds in medicinal chemistry programs.